Arialys Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11099 N Torrey Pines Rd Ste 290, La Joll...Phone Number
(858) 750-4700Website
www.arialysrx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Arialys Therapeutics
Based in La Jolla, California, Arialys Therapeutics is a biotechnology company with a focus on neuropsychiatry.Explore more
Arialys Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arialys Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Arialys Therapeutics is spiking on competitors!
Product Launch: Get notified when Arialys Therapeutics launches new products
Check if Arialys Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Arialys Therapeutics has new funding data
Click to see if Arialys Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Arialys Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Arialys Therapeutics
Arialys Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Arialys Therapeutics
Compare insights from companies similar to Arialys Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Arialys Therapeutics
<$5M
1-10
Private
$72.8M
2021
MM
Mitsuyuki MatsumotoScientific Founder and Chief Scientific Officer
Company Profile Activity
Activity Insights
Arialys Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Arialys Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Arialys Therapeutics.
Arialys Therapeutics financials insights
Gather financial insights about Arialys Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$58M
2025
Private Equity
$14.8M
Arialys Therapeutics Tech Stack
A closer look at the technologies used by Arialys Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Funding
, according to a recent Form D filing, has secured $14,800,017 in Private Equity funding.
Funding
Person-Based
Arialys Therapeutics News & Media
Arialys Therapeutics Initiates MAD Cohorts Having Completed All Planned SAD Cohorts in a Phase 1 Study of ART5803 for the Treatment of Autoimmune Neuropsychiatric Disease
LA JOLLA, Calif.--(BUSINESS WIRE)-- #ANRE--Arialys Therapeutics Initiates MAD Cohorts Having Completed All Planned SAD Cohorts in a Phase 1 Study of ART5803Arialys Therapeutics Appoints Sankalp Gokhale, M.D., Chief Medical Officer
LA JOLLA, Calif.--(BUSINESS WIRE)-- #ANRE--Arialys Therapeutics today announced the appointment of Sankalp “Sam” Gokhale, M.D., as Chief Medical Officer.Arialys Therapeutics Announces First Participants Dosed in a Phase 1 Clinical Trial of ART5803, a Precision Medicine for the Treatment of Autoimmune Neuropsychiatric Diseases
LA JOLLA, Calif.--(BUSINESS WIRE)-- #ANRE--Arialys Therapeutics Announces First Participants Dosed in a Phase 1 Clinical Trial of ART5803Arialys Therapeutics Appoints Peter Flynn, Ph.D., President and Chief Executive Officer
LA JOLLA, Calif.--(BUSINESS WIRE)-- #antiNMDAR--Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, today announced the appointment of Peter Flynn, Ph.D., as President and Chief Executive Officer. Dr. Flynn has more than 20 years of executive leadership experience in the biotech industry, from private start-ups to established publicly traded companies, scaling companies through key financings and pharma partnerships, advancing novel th
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Arialys Therapeutics
Sign Up For FreeTo access detailed company insights
Based in La Jolla, California, Arialys Therapeutics is a biotechnology company with a focus on neuropsychiatry.... Read More
